This page currently lists the bibliography of the paper that Byron Gajewski
and Steve Simon have submitted to Statistics in Medicine. Eventually,
this will expand to include additional papers and possibly include
annotations for some of the references.
Barnes K. "Pharma giants risk reputation through clinical trial
cost-cutting." Accessed on March 21, 2007.
http://www.in-pharmatechnologist.com/news/ng.asp?n=68150-chiltern-india-cost-clinical-trial-regulatory.
O'Hagan A, Buck CE, Daneshkhah A, Eiser JR, Garthwaite PH, Jenkinson DJ,
Oakley JE, Rakow T. Uncertain Judgements: Eliciting Experts' Probabilities,
New York: Wiley, 2006.
Garthwaite PH, Kadane JB, O'Hagan A. Statistical methods for eliciting
probability distributions. Journal of the American Statistical Association
2005; 100(470): 680-701.
Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical
Trials and Health-Care Evaluation. New York NY: John Wiley & Sons, 2004.
Tan SB, Machin D. Bayesian two-stage designs for phase II clinical trials.
Statistics in Medicine 2002; 21:1991-2012.
Mayo M, Gajewski BJ. Bayesian sample size calculations in phase II clinical
trials using informative conjugate priors. Controlled Clinical Trials 2004;
25(2): 157-167.
Gajewski BJ, Mayo MS. Bayesian sample size calculations in phase II
clinical trials using a mixture of informative priors. Statistics in Medicine
2006; 25(15): 2554-2566.
Johnson VA. A Bayesian chi-square test for goodness of fit. Annals of
Statistics 2004; 32(6): 306-317.
Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. New York:
Chapman and Hall, 2004.
Lindley, D.V. The future of statistics ' a Bayesian 21st century. Supp.
Adv. Applied Probability 1975; 7: 106-115.
Efron, B. Why isn't everyone a Bayesian? The American Statistician 1986;
40(1): 1-4. 12. Banerjee A, Tsiatis AB. Adaptive two-stage designs in phase
II clinical trials. Statistics in Medicine; 25(19): 3382-3395.
Berry DA. Bayesian clinical trials. Nature Reviews 2006, 5, 27-36.
07/08/2008.
